• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性髓系白血病中黏连蛋白复合物突变:临床和预后意义。

Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.

机构信息

Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;

出版信息

Blood. 2014 Feb 6;123(6):914-20. doi: 10.1182/blood-2013-07-518746. Epub 2013 Dec 13.

DOI:10.1182/blood-2013-07-518746
PMID:24335498
Abstract

Mutations in the cohesin complex are novel, genetic lesions in acute myeloid leukemia (AML) that are not well characterized. In this study, we analyzed the frequency, clinical, and prognostic implications of mutations in STAG1, STAG2, SMC1A, SMC3, and RAD21, all members of the cohesin complex, in a cohort of 389 uniformly treated AML patients by next generation sequencing. We identified a total of 23 patients (5.9%) with somatic mutations in 1 of the cohesin genes. All gene mutations were mutually exclusive, and STAG1 (1.8%), STAG2 (1.3%), and SMC3 (1.3%) were most frequently mutated. Patients with any cohesin complex mutation had lower BAALC expression levels. We found a strong association between mutations affecting the cohesin complex and NPM1. Mutated allele frequencies were similar between NPM1 and cohesin gene mutations. Overall survival (OS), relapse-free survival (RFS), and complete remission rates (CR) were not influenced by the presence of cohesin mutations (OS: hazard ratio [HR] 0.98; 95% confidence interval [CI], 0.56-1.72 [P = .94]; RFS: HR 0.7; 95% CI, 0.36-1.38 [P = .3]; CR: mutated 83% vs wild-type 76% [P = .45]). The cohesin complex presents a novel pathway affected by recurrent mutations in AML. This study is registered at www.clinicaltrials.gov as #NCT00209833.

摘要

在急性髓系白血病 (AML) 中,黏合蛋白复合物的突变是一种新的遗传病变,尚未得到很好的描述。在这项研究中,我们通过下一代测序分析了 389 名经统一治疗的 AML 患者队列中黏合蛋白复合物的成员 STAG1、STAG2、SMC1A、SMC3 和 RAD21 中突变的频率、临床和预后意义。我们总共鉴定出 23 名患者(5.9%)存在 1 个黏合蛋白基因的体细胞突变。所有基因突变均相互排斥,STAG1(1.8%)、STAG2(1.3%)和 SMC3(1.3%)突变最为常见。存在黏合蛋白复合物突变的患者 BAALC 表达水平较低。我们发现黏合蛋白复合物突变与 NPM1 之间存在很强的关联。NPM1 和黏合蛋白基因突变的突变等位基因频率相似。黏合蛋白突变的存在并不影响总生存(OS)、无复发生存(RFS)和完全缓解率(CR)(OS:风险比 [HR] 0.98;95%置信区间 [CI],0.56-1.72 [P =.94];RFS:HR 0.7;95% CI,0.36-1.38 [P =.3];CR:突变型 83% vs 野生型 76% [P =.45])。黏合蛋白复合物代表了 AML 中受反复突变影响的新途径。本研究在 www.clinicaltrials.gov 注册,编号为 #NCT00209833。

相似文献

1
Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.急性髓系白血病中黏连蛋白复合物突变:临床和预后意义。
Blood. 2014 Feb 6;123(6):914-20. doi: 10.1182/blood-2013-07-518746. Epub 2013 Dec 13.
2
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes.亚单位特异性分析黏连蛋白突变性髓系恶性肿瘤揭示了不同的发生和结局。
Leukemia. 2024 Sep;38(9):1992-2002. doi: 10.1038/s41375-024-02347-y. Epub 2024 Jul 20.
3
Whole Exome Sequencing Identifies Cohesin Component STAG1 Mutation in de novo Acute Myeloid Leukemia (FAB M2): A Pilot Study with Cytogenetics, Clinical and Prognostic Implications.全外显子组测序鉴定初发急性髓系白血病(FAB M2)中黏合蛋白成分 STAG1 突变:一项具有细胞遗传学、临床和预后意义的初步研究。
J Environ Pathol Toxicol Oncol. 2021;40(1):51-64. doi: 10.1615/JEnvironPatholToxicolOncol.2020035890.
4
Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.NPM1 突变型急性髓系白血病中的共存及协同突变
Leuk Res. 2017 May;56:7-12. doi: 10.1016/j.leukres.2017.01.027. Epub 2017 Jan 23.
5
STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemia.STAG2 突变重塑了黏连蛋白结构的空间染色质结构,从而驱动急性髓系白血病中的基因调控。
Cell Rep. 2024 Aug 27;43(8):114498. doi: 10.1016/j.celrep.2024.114498. Epub 2024 Jul 30.
6
mutations in acute myeloid leukemia.急性髓系白血病中的突变
Leuk Lymphoma. 2024 Jul;65(7):958-964. doi: 10.1080/10428194.2024.2328233. Epub 2024 Mar 20.
7
Genetic alterations of the cohesin complex genes in myeloid malignancies.髓系恶性肿瘤中黏连蛋白复合物基因的遗传改变。
Blood. 2014 Sep 11;124(11):1790-8. doi: 10.1182/blood-2014-04-567057. Epub 2014 Jul 8.
8
HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells.HDAC8抑制作用可阻断SMC3去乙酰化并延迟细胞周期进程,而不影响MCF7癌细胞中黏连蛋白依赖性转录。
J Biol Chem. 2016 Jun 10;291(24):12761-12770. doi: 10.1074/jbc.M115.704627. Epub 2016 Apr 12.
9
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.急性髓系白血病的发生是由独特的体细胞突变所定义的。
Blood. 2015 Feb 26;125(9):1367-76. doi: 10.1182/blood-2014-11-610543. Epub 2014 Dec 30.
10
Cohesin mutations in myeloid malignancies made simple.髓系恶性肿瘤中的黏连蛋白突变解析。
Curr Opin Hematol. 2018 Mar;25(2):61-66. doi: 10.1097/MOH.0000000000000405.

引用本文的文献

1
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with -mutated AML.骨髓增生异常相关及其他基因突变对接受强化治疗的FLT3突变型急性髓系白血病患者的影响。 (注:原文中“-mutated”推测可能是“FLT3-mutated”之类,这里补充完整以便更准确理解,实际翻译需根据准确原文信息)
Hemasphere. 2025 Jan 15;9(1):e70060. doi: 10.1002/hem3.70060. eCollection 2025 Jan.
2
A CD8 T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemia.CD8 T 细胞相关免疫评分可预测急性髓系白血病患者的生存情况并改善风险评估。
Front Immunol. 2024 Sep 12;15:1408109. doi: 10.3389/fimmu.2024.1408109. eCollection 2024.
3
Untangling the loops of mutations in myelodysplastic syndrome.
解析骨髓增生异常综合征中的突变环
Leuk Lymphoma. 2025 Jan;66(1):6-15. doi: 10.1080/10428194.2024.2400210. Epub 2024 Sep 12.
4
Cohesin mutations in acute myeloid leukemia.黏连蛋白突变与急性髓系白血病。
Leukemia. 2024 Nov;38(11):2318-2328. doi: 10.1038/s41375-024-02406-4. Epub 2024 Sep 9.
5
Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience.STAG2突变型髓系肿瘤中的克隆异质性:梅奥诊所的经验
Ann Hematol. 2024 Oct;103(10):4333-4336. doi: 10.1007/s00277-024-05971-x. Epub 2024 Aug 28.
6
Oncogenic Enhancers in Leukemia.白血病中的致癌增强子。
Blood Cancer Discov. 2024 Sep 3;5(5):303-317. doi: 10.1158/2643-3230.BCD-23-0211.
7
WNT inhibitory factor 1 (WIF1) is a novel fusion partner of RUNX family transcription factor 1 (RUNX1) in acute myeloid leukemia with t(12;21)(q14;q22).WNT抑制因子1(WIF1)是急性髓系白血病伴t(12;21)(q14;q22)中RUNX家族转录因子1(RUNX1)的一种新型融合伴侣。
J Hematop. 2024 Dec;17(4):245-249. doi: 10.1007/s12308-024-00597-4. Epub 2024 Jul 27.
8
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes.亚单位特异性分析黏连蛋白突变性髓系恶性肿瘤揭示了不同的发生和结局。
Leukemia. 2024 Sep;38(9):1992-2002. doi: 10.1038/s41375-024-02347-y. Epub 2024 Jul 20.
9
Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia.组学在急性髓系白血病诊断、预后及治疗中的应用。
Biomark Res. 2024 Jun 10;12(1):60. doi: 10.1186/s40364-024-00600-1.
10
Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts.不同癌症背景下黏着蛋白与 WNT 信号通路之间的合成致死性。
Cells. 2024 Mar 30;13(7):608. doi: 10.3390/cells13070608.